01066.HK
Shandong Weigao Group Medical Polymer Company Limited
HKSE · Healthcare · Medical - Instruments & Supplies · CN
HKD 3.27
+1.56%Year over year
Reported trailing growth
- Revenue
- +0.2%
- EBITDA
- -16.9%
- EBIT
- -18.8%
- EPS
- -24.8%
- Free cash flow
- -4.2%
- Operating cash flow
- +9.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -0.6%
- EBITDA
- -14.3%
- EBIT
- -16.6%
- Net income
- -16.4%
- EPS
- -16.9%
- Free cash flow
- +16.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026